25-08-2022 дата публикации
Номер: US20220265842A1
Автор:
Bryant Shaughn H.,
Hernandez,
Hobson Adrian D.,
Ihle Claire L.,
Jr. Axel,
Marvin Christopher C.,
McPherson Michael J.,
Oh Jason Z.,
Perng Olivia A.,
Santora Ling C.,
Waegell Wendy,
Wang Lu
Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R, R, and Rare as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R, R, and Rare as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same. 3. The antibody drug conjugate of claim 1 , wherein Ris hydrogen and Ris hydrogen.4. The antibody drug conjugate of claim 1 , wherein Ris fluoro and Ris hydrogen.5. The antibody drug conjugate of claim 1 , wherein Ris fluoro and Ris fluoro.6. The antibody drug conjugate of claim 1 , wherein Ris —P(═O)(OH).7. The antibody drug conjugate of claim 1 , wherein Ris hydrogen.8. The antibody drug conjugate of claim 1 , wherein -AA1-(AA2)-(AA3)- is selected from the group consisting of -Gly-Glu-; -Ala-Ala-; -Glu-Ala-Ala-; -Gly-Lys-; -Glu-; -Glu-Ser-Lys-; and -Gly-Ser-Lys-.912.-. (canceled)13. The antibody drug conjugate of claim 2 , wherein:m is 0 or 1;p is 1; andR is a bond14. The antibody drug conjugate of claim 2 , wherein R is a bond claim 2 , p is 1 claim 2 , m is 0 claim 2 , w is 0 claim 2 , and q is 0.15. The antibody drug conjugate of claim 2 , wherein R is a bond claim 2 , p is 1 claim 2 , m is 0 claim 2 , w is 0 claim 2 , and q is 1.1617.-. (canceled)18. The antibody drug conjugate of claim 1 , selected from the group consisting of compounds listed in Table 5 claim 1 , wherein n is 1 claim 1 , 2 claim 1 , 3 claim 1 , 4 claim 1 , 5 claim 1 , 6 claim 1 , 7 claim 1 , 8 claim 1 , 9 claim 1 , or 10.19. (canceled)20. The antibody drug conjugate of claim 1 , selected from the group consisting of compounds listed in Table 6A claim 1 , wherein n is 1 claim 1 , 2 claim 1 , 3 claim 1 , 4 claim 1 , 5 claim 1 , 6 claim 1 , 7 claim 1 , 8 claim 1 , 9 claim 1 , or 10.21. (canceled)22. The antibody drug conjugate of claim 1 , selected from the group consisting of compounds listed in Table 6B claim 1 , wherein ...
Подробнее